NR1H4 and metabolic dysfunction-associated steatotic liver disease: Based on our research, we propose a possible molecular mechanism involving the dual receptor-activating nature of withaferin A on LXR/FXR activation that ameliorates high-calorie diet-induced NAFLD (Figure 7).